Amlobenz
Product Images NDC 21695-866

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amlobenz (NDC 21695-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure01 (241e7477 Ecae 4f84 8410 Bbfaa9f57ed0 01)

FDA Label Image

Structure02 (241e7477 Ecae 4f84 8410 Bbfaa9f57ed0 02)

FDA Label Image

Amlodipin Besylate And Benazepril HCl 5mg/10mg (241e7477 Ecae 4f84 8410 Bbfaa9f57ed0 03)

Amlodipin Besylate And Benazepril HCl 5mg/10mg (241e7477 Ecae 4f84 8410 Bbfaa9f57ed0 03)
This is a description of a medication with the brand name 'Peel'. It is mainly composed of two active ingredients - Amlodipine Besylate and Benazepril HCI, and it comes in the form of hard gelatin capsules of ivory color cap and body. It is manufactured by Dr. Reddy's Laboratories Limited in India and each capsule contains 5mg of Benazepril HCI and Amlodipine Besylate. The product should be stored at room temperature and should be kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.